Opioid addiction and opioid-related deaths have increased dramatically in the United States in the past decade and healthcare provider organizations across the country are grappling with finding ways to curb the nation’s opioid epidemic.
According to the Centers for Disease Control and Prevention (CDC), deaths from drug overdoses in the U.S. totaled more than 63,600 in 2016, with 42,249 of those deaths attributed to opioids. The death rate from opioid overdoses was five times higher in 2016 than in 1999. In a state-by-state analysis, in 2016 West Virginia had the highest death rate per 100,000 population, followed by Ohio, New Hampshire and Pennsylvania.
During a webinar April 25 sponsored by the College of Healthcare Information Management Executives (CHIME) Opioid Task Force, executive leaders at the Danville, Pa.-based Geisinger Health System outlined a multifaceted, data-driven initiative by health system leaders to address the opioid crisis in Pennsylvania.
“Opioids have been a challenge for us,” acknowledged John Kravitz, CIO at Geisinger Health System, citing the statistic that Pennsylvania’s opioid overdose death rate was the fourth highest in the country. In 2016, there were 4,642 drug-related drug deaths in the state, with 85 percent involving opioids and one in four being prescription opioids. What’s more, many of the counties with the highest death rates in 2016 were served by Geisinger Health System.
Kravitz, along with Richard Taylor, M.D., Geisinger’s chief medical information officer (CMIO) and Michael Evans, Geisinger’s vice president of enterprise pharmacy and chief pharmacy officer, detailed the health system’s effort to utilize data and health IT tools to change providers’ prescribing practices. As a result of this effort, the health system has slashed opioid prescriptions in half, from a monthly average of 60,000 opioid prescriptions to 31,000 prescriptions per month.
Geisinger Health System consists of 12 hospitals and 700 clinics with 2,400 employed physicians and more than 4,000 affiliated physicians. The health system’s reach includes more than 3 million residents in 45 counties in central, south-central and northeast Pennsylvania and southern New Jersey. As an integrated system, Geisinger also operates a health plan with 600,000 members.
According to Kravitz, physician leadership recognized the opioid crisis in its own communities and wanted to reverse the trends. By limiting or eliminating the prescribing of opioids in a clinical setting, physician leadership proposed, Geisinger could minimize or prevent a patient’s exposure to the drugs and the consequent risk of the patient developing an addiction that might lead to an overdose and death.
Physician leaders also recognized that reducing opioid addictions could ease the burden on the health system. An analysis of 942 patients in the Geisinger system who overdosed on opioids found a steep increase in the use of acute care, and especially emergency department services, prior to an overdose, according to Kravitz.
He emphasized that addressing prescription opioid abuse requires a multifaceted, holistic effort that includes encouraging effective non-opioid therapies for pain management. “Technology is not the silver bullet to solving this problem; there is no single silver bullet,” he said.
Kravitz noted that the original intent of the initiative wasn’t to reduce opioid prescriptions, but to ensure appropriate pain management with the recognition than non-opioid therapies would help patients avoid the side effects of opioids and reduce the potential risk of addiction. In the surgical setting, Geisinger leaders designed a pain management program in which patients and their families were counseled to expect some manageable pain after relatively minor procedures. At discharge, providers were encouraged to offer nonaddictive alternatives to opioids for managing pain, such as Tylenol, nonsteroidal anti-inflammatory drugs or other novel medications. If a physician decided an opioid prescription was in the best interest of a patient, the physician was encouraged to use the smallest effective dosage prescribed for three days or less, Kravitz said.
In addition, for chronic pain patients and patients at risk of addiction, Geisinger recommended therapies such as rehabilitation, exercise, cognitive behavioral therapies, yoga and acupuncture rather than opioids. Taylor noted that a Geisinger study found that opioids are not helpful in treating chronic pain, and that side effects of chronic opioid therapy include risk of addiction and depression and other potential health problems.
Geisinger project leaders developed and initiated several approaches that focused on changing physician practice patterns to reduce the prescribing of opioids. Data and IT were foundational to these efforts, as physician leadership developed a provider dashboard linked to the electronic health record (EHR) to identify current practice patterns among Geisinger providers. With this baseline data, Geisinger physician leaders found that providers varied greatly in their opioid prescribing patterns, with a relatively small number being heavy prescribers. They then used that information to first target the outliers and provide them with best practices for pain management.
“Having the dashboard linked into EHR has been critical to success,” Kravitz said. “When we meet with physician provider groups, the typical response is, ‘I had no idea that I was prescribing that much controlled substance, that much opioid.’ It has helped prescribers as they are managing their own patient populations. It shows the fill data around what the patients are doing and the data will tell you if there are patients going to three different providers for three different medications and filled at three different pharmacies.”
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.